These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10702720)

  • 1. Diagnostic value of nucleic-acid-sequence- based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients.
    Goossens VJ; Blok MJ; Christiaans MH; van Hooff JP; Sillekens P; Höckerstedt K; Lautenschlager I; Middeldorp JM; Bruggeman CA
    Intervirology; 1999; 42(5-6):373-81. PubMed ID: 10702720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification.
    Greijer AE; Verschuuren EA; Harmsen MC; Dekkers CA; Adriaanse HM; The TH; Middeldorp JM
    J Clin Microbiol; 2001 Jan; 39(1):251-9. PubMed ID: 11136779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.
    Blok MJ; Lautenschlager I; Goossens VJ; Middeldorp JM; Vink C; Höckerstedt K; Bruggeman CA
    J Clin Microbiol; 2000 Dec; 38(12):4485-91. PubMed ID: 11101584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
    Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
    J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
    Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
    J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
    Gerna G; Baldanti F; Middeldorp JM; Furione M; Zavattoni M; Lilleri D; Revello MG
    J Clin Microbiol; 1999 Apr; 37(4):902-11. PubMed ID: 10074499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification.
    Blok MJ; Goossens VJ; Vanherle SJ; Top B; Tacken N; Middeldorp JM; Christiaans MH; van Hooff JP; Bruggeman CA
    J Clin Microbiol; 1998 May; 36(5):1341-6. PubMed ID: 9574702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular-based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipients.
    Kulkarni A; Westmoreland D; Fox JD
    Clin Microbiol Infect; 2001 Apr; 7(4):179-86. PubMed ID: 11422239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different profiles of cytomegalovirus RNA transcripts and anti-cytomegalovirus IgM antibodies in renal transplant recipients.
    Goossens VJ; Vink C; Mullers W; Middeldorp JM; Bruggeman CA
    J Clin Virol; 2001 Dec; 23(1-2):87-95. PubMed ID: 11595587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays.
    Amorim ML; Cabeda JM; Seca R; Mendes AC; Castro AP; Amorim JM
    BMC Infect Dis; 2001; 1():2. PubMed ID: 11389774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary report for the application of nucleic acid sequence-based amplification in detection of human cytomegalovirus (HCMV) late pp67 mRNA for diagnosis of HCMV infection.
    Pairoj W; Srichunrusami C; Chantratita W; Bodhiphala P; Sungkanuparph S; Vibhagool A
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S28-34. PubMed ID: 10865403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of CMV early and late transcript detection with NASBA in bronchoalveolar lavages.
    Keightley MC; Rinaldo C; Bullotta A; Dauber J; St George K
    J Clin Virol; 2006 Dec; 37(4):258-64. PubMed ID: 16978918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection.
    Witt DJ; Kemper M; Stead A; Sillekens P; Ginocchio CC; Espy MJ; Paya CV; Smith TF; Roeles F; Caliendo AM
    J Clin Microbiol; 2000 Nov; 38(11):3994-9. PubMed ID: 11060058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onset and duration of cytomegalovirus immediate early 1 mRNA expression in the blood of renal transplant recipients.
    Goossens VJ; Christiaans MH; Blok MJ; Terporten PH; Sillekens P; Lukacsi A; Van Hooff JP; Bruggeman CA
    J Med Virol; 2004 Jan; 72(1):94-101. PubMed ID: 14635016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex real-time NASBA for monitoring expression dynamics of human cytomegalovirus encoded IE1 and pp67 RNA.
    Greijer AE; Adriaanse HM; Dekkers CA; Middeldorp JM
    J Clin Virol; 2002 Feb; 24(1-2):57-66. PubMed ID: 11744429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCMV pp67-mRNA detection by nucleic acid sequence-based amplification in renal transplant patients.
    Merlino C; Bergallo M; Gregori G; Sinesi F; Bollero C; Cavallo R
    New Microbiol; 2002 Jan; 25(1):1-8. PubMed ID: 11837384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between pp65 antigenemia, RT-PCR and viruria for cytomegalovirus detection in kidney transplant recipients.
    Solà R; Rabella N; Guirado LL; Díaz JM; Facundo C; García R
    Transplant Proc; 2005 Nov; 37(9):3768-9. PubMed ID: 16386533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.
    Halwachs-Baumann G; Wilders-Truschnig M; Enzinger G; Eibl M; Linkesch W; Dornbusch HJ; Santner BI; Marth E; Kessler HH
    J Clin Virol; 2001 Jan; 20(1-2):49-57. PubMed ID: 11163583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of cytomegalovirus in renal transplant recipients: comparison of PCR, NASBA, pp65 antigenemia, and viral culture.
    Goossens VJ; Blok MJ; Christiaans MH; Sillekens P; Middeldorp JM; Bruggeman CA
    Transplant Proc; 2000 Feb; 32(1):155-8. PubMed ID: 10701004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.